Methylnaltrexone prevents morphine‐induced delay in oral‐cecal transit time without affecting analgesia: A double‐blind randomized placebo‐controlled trial

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical pharmacology and therapy

• Publication date

  1996-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0009-9236(96)90117-4PMID 8612393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE DISTRIBUTION OF METHIONINE‐ENKEPHALIN AND LEUCINE‐ENKEPHALIN IN THE BRAIN AND PERIPHERAL TISSUES

  1997cited by this paper
• Opioid analgesics and antagonists

  1996cited by this paper
• Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine.

  1995cited by this paper
• A Dose-Response Study of the Effects of Intravenous Midazolam on Cold Pressor-Induced Pain

  1995cited by this paper
• Treatment of Opioid-Induced Constipation with Oral Naloxone: A Pilot Study

  1993cited by this paper
• TACRINE IN ALZHEIMER'S DISEASE. AUTHOR'S REPLIES

  1993cited by this paper
• Dose‐Related Antagonism of the Emetic Effect of Morphine by Methylnaltrexone in Dogs

  1993cited by this paper
• Constipation related to narcotic therapy: A protocol for nurses and patients

  1992cited by this paper
• Treatment of opioid‐induced constipation with oral naloxone: A pilot study

  1992cited by this paper
• Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster.

  1992cited by this paper
• Relieving constipation and pain in the terminally ill.

  1991cited by this paper
• Oral naloxone in opioid-associated constipation.

  1991cited by this paper
• Human pain responsivity in a tonic pain model: Psychological determinants

  1989cited by this paper
• Managing your patients' adverse reactions to narcotics.

  1989cited by this paper
• Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans.

  1989cited by this paper
• Assay for methylnaltrexone in rat brain regions and serum by high-performance liquid chromatography with coulometric electrochemical detection

  1989cited by this paper
• Naloxone infusion after prophylactic epidural morphine: effects on incidence of postoperative side-effects and quality of analgesia

  1988cited by this paper
• Constipation in the cancer patient: causes and management.

  1987cited by this paper
• Oral naloxone antagonizes loperamide-induced delay of orocecal transit

  1987cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.

  1986cited by this paper
• The Psychology of pain

  1986cited by this paper
• Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.

  1986cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Epidural Morphine and Methylprednisolone: New Therapy for Recurrent Low-Back Pain

  1986cited by this paper
• The central and peripheral influences of opioids on gastrointestinal propulsion.

  1985cited by this paper
• Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate.

  1985cited by this paper
• Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.

  1985cited by this paper
• The use of quaternary narcotic antagonists in opiate research.

  1985cited by this paper
• Oral morphine in chronic cancer pain

  1984cited by this paper
• Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.

  1983cited by this paper
• Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.

  1982cited by this paper
• INHIBITION OF GASTROINTESTINAL TRANSIT AND ANTINOCICEPTIVE EFFECTS OF MORPHINE AND FK 33-824 IN RATS ARE DIFFERENTLY PREVENTED BY NALOXONE AND BY ITS N-METHYL QUATERNARY ANALOG

  1981cited by this paper
• Opiates and the gastrointestinal tract.

  1980cited by this paper
• Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action.

  1980cited by this paper
• Alterations of the colonic flora and their effect on the hydrogen breath test.

  1978cited by this paper
• Central and peripheral actions of morphine on intestinal transit.

  1978cited by this paper
• THE DISTRIBUTION OF METHIONINE‐ENKEPHALIN AND LEUCINE‐ENKEPHALIN IN THE BRAIN AND PERIPHERAL TISSUES

  1977cited by this paper
• Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.

  1977cited by this paper
• Use of breath hydrogen (H2) in the study of carbohydrate absorption

  1977cited by this paper
• Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

  1975cited by this paper
• Mediation by 5-hydroxytryptamine of morphine stimulant actions in dog intestine.

  1973cited by this paper
• The psychology of pain.

  1970cited by this paper
• Response of experimental pain to analgesic drugs: I. Morphine, aspirin, and placebo

  1966cited by this paper
• Effects of morphine and other drugs on motility of the terminal ileum.

  1959cited by this paper

• The Efficacy and Safety of Methylnaltrexone in Cancer patients with Opioid-induced Constipation: A Systematic Review and Meta-analysis

  2025cites this paper
• Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose

  2023cites this paper
• Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis

  2023cites this paper
• Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials

  2023cites this paper
• Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation

  2023cites this paper
• Loperamide Induced Recurrent Torsades de Pointes: A Case Report

  2021cites this paper
• Perioperative Subcutaneous Methylnaltrexone Does Not Enhance Gastrointestinal Recovery after Posterior Short-Segment Spinal Arthrodesis Surgery: A Randomized Controlled Trial.

  2021cites this paper
• The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies

  2021cites this paper
• First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.

  2021cites this paper
• Design and feasibility of a double-blind, randomized trial of peri-operative methylnaltrexone for postoperative ileus prevention after adult spinal arthrodesis.

  2021cites this paper
• Pharmacological Treatments for Constipation and Opioid-Induced Constipation

  2021cites this paper
• Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies

  2021cites this paper
• Antagonistas periféricos de los receptores opioides Mu en el tratamiento del estreñimiento inducido por opioides: revisión.

  2020cites this paper
• Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.

  2020cites this paper
• Peripheral acting mu opioid receptor antagonists in the treatment of opioid-induced constipation: review

  2020cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis

  2020cites this paper
• Pharmacokinetics and Pharmacology of Drugs Used in Children

  2019cites this paper
• Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?

  2019cites this paper
• Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone

  2019cites this paper
• European society of neurogastroenterology and motility guidelines on functional constipation in adults

  2019cites this paper
• Development of a postoperative ileus risk assessment scale: identification of intraoperative opioid exposure as a significant predictor after spinal surgery.

  2019cites this paper
• Opioids as substrates and inhibitors of the genetically highly variable organic cation transporter OCT1.

  2019cites this paper
• Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?

  2018cites this paper
• Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

  2018cites this paper
• Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

  2018cites this paper
• Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain

  2018cites this paper
• Constipations as a side effect of opioid anti-pain therapy – current and future treatment methods

  2018cites this paper
• Identifying and Treating Opioid Side Effects

  2018cites this paper
• Effects of naloxegol on whole gut transit in opioid‐naïve healthy subjects receiving codeine: A randomized, controlled trial

  2018cites this paper
• Methylnaltrexone bromide for the treatment of opioid-induced constipation

  2018cites this paper
• Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.

  2017cites this paper
• The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature

  2017cites this paper
• Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects

  2016cites this paper
• Opioid-induced constipation: advances and clinical guidance

  2016cites this paper
• Chewing Gum: A Funny Way Opposed To Postoperative Ileus For Gynecological Operations Jinekolojik Operasyonlarda Postoperatif İleusu Önlemek İçin Tuhaf Bir Yol: Sakiz Çiğneme

  2015cites this paper
• Methylnaltrexone for opioid-induced constipation in patients at the end of life.

  2015cites this paper
• Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial.

  2015cites this paper
• 临床用阿片受体拮抗剂研究进展 Research Progress of Opioid Receptor Antagonist Used in Clinic

  2015cites this paper
• Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities

  2015cites this paper
• Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

  2015cites this paper
• Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials

  2015cites this paper
• Research Progress of Opioid Receptor Antagonist Used in Clinic

  2015cites this paper
• Opioid-induced constipation

  2015cites this paper
• Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension

  2015cites this paper
• Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain

  2015cites this paper
• Detection of drug effects on gastric emptying and contractility using a wireless motility capsule

  2014cites this paper
• Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers

  2014cites this paper
• Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus

  2013cites this paper
• Expert Review of Gastroenterology & Hepatology

  2013cites this paper
• Effects of methylnaltrexone on guinea pig gastrointestinal motility

  2013cites this paper
• Morphine and Metastasis: From Bench to Bedside

  2013cites this paper
• Methylnaltrexone for the treatment of opioid-induced constipation

  2013cites this paper
• Treatment of Opioid-Induced Constipation: Focus on the Peripheral μ-Opioid Receptor Antagonist Methylnaltrexone

  2013cites this paper
• A practical approach to diagnosis and management of functional constipation in adults

  2013cites this paper
• Opioid-Induced Bowel Dysfunction

  2012cites this paper
• Meta-analysis of Oro-cecal Transit Time in Fasting Subjects

  2012cites this paper
• Opioid Induced Constipation

  2012cites this paper
• Management of Opioid-Induced Constipation in Cancer Patients

  2012cites this paper
• Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.

  2012cites this paper
• Methylnaltrexone

  2012cites this paper
• Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome

  2012cites this paper
• Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?

  2012cites this paper
• Constipation - Causes, Diagnosis and Treatment

  2012cites this paper
• Optimising opioids for cancer pain : investigating the basis of inter-individual analgesic response and side-effect profile

  2012cites this paper
• Role of Gum Chewing on the Duration of Postoperative Ileus Following Ileostomy Closure Done for Typhoid Ileal Perforation: A Prospective Randomized Trial

  2012cites this paper
• Ist die pharmakologische Therapie der Obstipation in der Palliativmedizin evidenzbasiert?

  2012cites this paper
• [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].

  2012cites this paper
• New treatment options for chronic constipation: mechanisms, efficacy and safety.

  2011cites this paper
• Quantitative determination of methylnaltrexone in human serum using liquid chromatography-tandem mass spectrometry.

  2011cites this paper
• Interval Signet-Ring Cell Adenocarcinoma of the Colon: Missed or De Novo?

  2011cites this paper
• Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide

  2011cites this paper
• Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults

  2011cites this paper
• Safety and Efficacy of Methylnaltrexone in Shortening the Duration of Postoperative Ileus Following Segmental Colectomy: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

  2011cites this paper
• Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingness-to-pay and cost-benefit analysis.

  2011cites this paper
• Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

  2011cites this paper
• Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers

  2011cites this paper
• Der Schmerz als Teil des protektiven Systems

  2010cites this paper
• Anaesthesia and Perioperative Management for Anorectal and Colonic Surgery

  2010cites this paper
• Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide

  2010cites this paper
• Opioidantagonisten gemischtwirkende Agonisten/ Antagonisten und partielle Agonisten

  2010cites this paper
• Opioidwirkung abhängig von Affinität, intrinsischer Aktivität und Lipophilie

  2010cites this paper
• In Vitro Metabolism and Identification of Human Enzymes Involved in the Metabolism of Methylnaltrexone

  2010cites this paper
• Gastrointestinale Motilitätsstörungen auf der Intensivstation – Ursachen, Konsequenzen und Therapie

  2010cites this paper
• Metabolism of Intravenous Methylnaltrexone in Mice, Rats, Dogs, and Humans

  2010cites this paper
• In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure

  2010cites this paper
• Postoperativer Einsatz von Opioiden

  2010cites this paper
• Hinterhorn des Rückenmarks — Ort der Modulation nozizeptiver Afferenzen

  2010cites this paper
• Neurophysiologische Grundlagen chronischer Schmerzen

  2010cites this paper
• Possible causes of constipation Organic Functional Drug-induced Diverticulitis Prolonged colon Opioids Tumors passage Antibiotics Inflammation in the impaired defecation Anticholinergics anal area Insufficient intake of Antihypertensive drugs Neurological fluids Anticonvulsive drugs disorders Low fi

  2010cites this paper
• Opioide in der Intensivmedizin

  2010cites this paper
• Rationale zur Opioidtherapie bei Schmerzen

  2010cites this paper
• Wirkungen und Nebenwirkungen der Opioide

  2010cites this paper
• Opioide im Rahmen der Allgemeinanästhesie

  2010cites this paper
• Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs

  2009cites this paper
• Opioid side effects and management

  2009cites this paper
• Emerging drugs for chronic constipation

  2009cites this paper
• Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.

  2009cites this paper
• Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use

  2009influential citation
• Recent advances in the use of opioids for cancer pain

  2009cites this paper